Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R J Thatcher

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Molecular Cancer Therapeutics|August 19, 2007
Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivoGhenet K Hagos, Robert E Carroll, Tatiana Kouznetsova, et al.
Ebiomedicine|March 22, 2021
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic developmentCutler T Lewandowski, Md Wasim Khan, Manel BenAissa, et al.
The Journal of Biological Chemistry|December 20, 2015
Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 ProteinIrida Kastrati, Marton I Siklos, Esther L Calderon-Gierszal, et al.
Nitric Oxide : Biology and Chemistry|May 20, 2008
Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionalityTareisha Dunlap, Samer O Abdul-Hay, R Esala P Chandrasena, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 14, 2016
Time-Gated Detection of Cystathionine γ-Lyase Activity and Inhibition with a Selective, Luminogenic Hydrogen Sulfide SensorYao Yao, Chen Kong, Liang Yin, et al.
Journal of Medicinal Chemistry|January 25, 2017
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast CancerRui Xiong, Jiong Zhao, Lauren M Gutgesell, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
Estrogenic activity of the equine estrogen metabolite, 4-methoxyequileninMinsun Chang, Cassia R Overk, Irida Kastrati, et al.
Journal of Molecular Biology|July 6, 2007
Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor designMelissa May, Shahila Mehboob, Debbie C Mulhearn, et al.
The Journal of Biological Chemistry|January 23, 2009
Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the NucleusZhican Wang, Gihani T Wijewickrama, Kuan-Wei Peng, et al.
Frontiers in Pharmacology|June 26, 2026
Inhibition of pathogenic tau signaling via blocking of the phosphatase-activating domain by novel small moleculesRaghad Nowar, Ganga Reddy Velma, Jiqiang Fu, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|August 19, 2007
Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivoGhenet K Hagos, Robert E Carroll, Tatiana Kouznetsova, et al.
Ebiomedicine|March 22, 2021
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic developmentCutler T Lewandowski, Md Wasim Khan, Manel BenAissa, et al.
The Journal of Biological Chemistry|December 20, 2015
Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 ProteinIrida Kastrati, Marton I Siklos, Esther L Calderon-Gierszal, et al.
Nitric Oxide : Biology and Chemistry|May 20, 2008
Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionalityTareisha Dunlap, Samer O Abdul-Hay, R Esala P Chandrasena, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 14, 2016
Time-Gated Detection of Cystathionine γ-Lyase Activity and Inhibition with a Selective, Luminogenic Hydrogen Sulfide SensorYao Yao, Chen Kong, Liang Yin, et al.
Journal of Medicinal Chemistry|January 25, 2017
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast CancerRui Xiong, Jiong Zhao, Lauren M Gutgesell, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
Estrogenic activity of the equine estrogen metabolite, 4-methoxyequileninMinsun Chang, Cassia R Overk, Irida Kastrati, et al.
Journal of Molecular Biology|July 6, 2007
Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor designMelissa May, Shahila Mehboob, Debbie C Mulhearn, et al.
The Journal of Biological Chemistry|January 23, 2009
Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the NucleusZhican Wang, Gihani T Wijewickrama, Kuan-Wei Peng, et al.
Frontiers in Pharmacology|June 26, 2026
Inhibition of pathogenic tau signaling via blocking of the phosphatase-activating domain by novel small moleculesRaghad Nowar, Ganga Reddy Velma, Jiqiang Fu, et al.
Pageof 14